CLINICAL_TRIALS trial_result · 2015-04-24

Clinical Trial Update: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome [Phase 2]

Phase 2 open-label, multi-center trial of eculizumab in adults with atypical hemolytic uremic syndrome has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Atypical Hemolytic-Uremic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-04-24